A Japanese early phase 2 study of S-444823 ointment in patients with atopic dermatitis

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220964

Enrollment

230

Registered

2010-01-14

Start date

2010-01-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

investigational material(s) Generic name etc : S-444823 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational mate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient satisfies the diagnostic criteria for AD as defined by the criteria of Hanifin & Rajka, etc.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Change in the VAS Change in the EASI (Eczema area and severity index)	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026